Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.44 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL9660285 | 1.00 | TSHR (0.71) | TSHRALDH1A1TDP1THRBLMNA | |
| Heptane SCHEMBL9531613 | 0.96 | TSHR (0.79) | TSHRALDH1A1TDP1THRBLMNA | |
| Tetradecane SCHEMBL28244850 | 0.96 | TSHR (0.79) | TSHRALDH1A1TDP1THRBLMNA | |
| 1,2-Dichloroethane SCHEMBL28113335 | 0.92 | TSHR (0.86) | TSHRALDH1A1TDP1THRBLMNA | |
| Pentane SCHEMBL7087547 | 0.91 | — | — | |
| Hexane SCHEMBL1233732 | 0.89 | TSHR (0.59) | TSHRALDH1A1TDP1THRBLMNA | |
| SCHEMBL276808 | 0.87 | — | — | |
| Hexane SCHEMBL8845002 | 0.87 | TSHR (0.92) | TSHRALDH1A1TDP1THRBLMNA | |
| SCHEMBL9285670 | 0.87 | TSHR (0.92) | TSHRALDH1A1TDP1THRBLMNA | |
| Hexane SCHEMBL8668030 | 0.87 | TSHR (0.79) | TSHRALDH1A1TDP1THRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115093347-B | Hapten for detecting cypermethrin content and application thereof | 云南省烟草质量监督检测站 | 2023-09-12 | — | — | CN | claimed |
| CN-115093347-A | Hapten for detecting cypermethrin content and application thereof | 云南省烟草质量监督检测站 | 2022-09-23 | — | — | CN | claimed |
| EP-1716145-B1 | DIHYDROTETRABENAZINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | CAMBRIDGE LAB IRELAND LTD (IE) | 2008-08-27 | — | — | EP | claimed |
| CN-115093347-B | Hapten for detecting cypermethrin content and application thereof | 云南省烟草质量监督检测站 | 2023-09-12 | — | — | CN | disclosed |
| CN-115093347-A | Hapten for detecting cypermethrin content and application thereof | 云南省烟草质量监督检测站 | 2022-09-23 | — | — | CN | disclosed |
| EP-3214086-B1 | SUBSTITUTED DIHYDROPYRROLOPYRAZOLE COMPOUND | UBE INDUSTRIES (JP) | 2021-09-22 | — | — | EP | disclosed |
| US-10968238-B2 | Substituted dihydropyrrolopyrazole compound | UBE INDUSTRIES, LTD. (JP) | 2021-04-06 | — | — | US | disclosed |
| CN-111303051-A | Method for preparing 5- (3, 6-dihydro-2, 6-dioxo-4-trifluoromethyl-1 (2H) -pyrimidyl) thiophenol | 东部福阿母韩农株式会社 | 2020-06-19 | — | — | CN | disclosed |
| US-10322998-B2 | Heterogeneous foldamers containing α, β, and/or γ-amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2019-06-18 | — | — | US | disclosed |
| US-10131679-B2 | Substituted dihydropyrrolopyrazole compound | UBE INDUSTRIES, LTD. (JP) | 2018-11-20 | — | — | US | disclosed |
| US-10007183-B2 | Compound for forming organic film, and organic film composition using the same, process for forming organic film, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-06-26 | — | — | US | disclosed |
| US-4447360-A | Intermediates for thia-aza compounds with a β-lactam ring | CIBA-GEIGY CORPORATION (US) | 1984-05-08 | — | — | US | disclosed |
| US-4436661-A | INTERMEDIATES FOR PENICILLIN ANTIBIOTICS | CIBA-GEIGY CORPORATION (US) | 1984-03-13 | — | — | US | disclosed |
| US-4420630-A | BINDERS FOR PHOTOGRAPHY | EASTMAN KODAK COMPANY (US) | 1983-12-13 | — | — | US | disclosed |
| US-4331676-A | 2-PENEM COMPOUNDS UNSUBSTITUTED IN THE 6 POSITION | CIBA-GEIGY CORPORATION (US) | 1982-05-25 | — | — | US | disclosed |
| US-4259469-A | DESIRABLE SOLUBILITY CHARACTERISTICS FOR USE IN PHOTOLITHOGRAPHY | EASTMAN KODAK COMPANY (US) | 1981-03-31 | — | — | US | disclosed |
| US-4083863-A | PESTICIDES | AMERICAN CYANAMID CORPORATION (US) | 1978-04-11 | — | — | US | disclosed |
| US-4027029-A | Diazepine derivatives | CIBA-GEIGY CORPORATION (US) | 1977-05-31 | — | — | US | disclosed |
| US-4009208-A | N,N'-HEPTAMETHYLENEBIS(4-METHOXYBENZAMIDE) | STERLING DRUG INC. (US) | 1977-02-22 | — | — | US | disclosed |
| US-3960945-A | 4-[-(Alkoxy or polyhaloalkoxy)-benzamido]cyclohexanones | STERLING DRUG INC. (US) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10322998-B2 | Heterogeneous foldamers containing α, β, and/or γ-amino acids | DNPEP, PRKCSH, BCAT1 | TSHR 3486/4885ALDH1A1 3234/4885TDP1 1943/4885 |
| US-10007183-B2 | Compound for forming organic film, and organic film composition using the same, process for forming organic film, and patterning process | OR10J3, RER1, OLA1 | TSHR 4347/4885ALDH1A1 1407/4885TDP1 3714/4885 |
| US-10131679-B2 | Substituted dihydropyrrolopyrazole compound | QDPR, CYP2D6, DCLK3 | TSHR 2798/4885ALDH1A1 246/4885TDP1 2475/4885 |
| US-10968238-B2 | Substituted dihydropyrrolopyrazole compound | QDPR, CYP2D6, KCNJ11 | TSHR 2880/4885ALDH1A1 190/4885TDP1 2120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.